NCT05112016 Long-term Cohort Study of Mesorectal Excision for Rectal Cancer
| NCT ID | NCT05112016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kantonsspital Winterthur KSW |
| Condition | Rectum |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2007-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2007-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this cohort study is to record, evaluate and compare the surgical, oncological as well as the functional outcome and Quality of life after mesorectal excision for rectal cancer
Eligibility Criteria
Inclusion Criteria: * Men and Women \>18 years * Patients with rectal cancer * Underwent mesorectal excision * Agreed to fill in a validated questionnaires before surgery and after stoma reversal * Informed consent Exclusion Criteria: * Age \< 18 * No informed consent (no general consent, no consent to use personal data for research purpose)
Contact & Investigator
Michel Adamina, Prof/MD/MSc
PRINCIPAL INVESTIGATOR
Kantonsspital Winterthur KSW
Frequently Asked Questions
Who can join the NCT05112016 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rectum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05112016 currently recruiting?
Yes, NCT05112016 is actively recruiting participants. Contact the research team at michel.adamina@ksw.ch for enrollment information.
Where is the NCT05112016 trial being conducted?
This trial is being conducted at Winterthur, Switzerland.
Who is sponsoring the NCT05112016 clinical trial?
NCT05112016 is sponsored by Kantonsspital Winterthur KSW. The principal investigator is Michel Adamina, Prof/MD/MSc at Kantonsspital Winterthur KSW. The trial plans to enroll 250 participants.